Histamine release from mast cells and monocytes: the effects of azelastine, reproterol and vitamin A-analogues.
Bolsmann
K
K
Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, RWTH Aachen, Germany.
Braam
U
U
Eichelberg
D
D
Greven
T
T
Jungbluth
C
C
Schmutzler
W
W
Zwadlo-Klarwasser
G
G
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology; D002338:Carotenoids / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005050:Etretinate / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology; D007641:Keratolytic Agents / Q000494:pharmacology; D008407:Mast Cells / Q000187:drug effects* / Q000378:metabolism; D009921:Metaproterenol / Q000031:analogs & derivatives / Q000494:pharmacology; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D010793:Phthalazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000494:pharmacology; D013806:Theophylline / Q000031:analogs & derivatives / Q000494:pharmacology; D019207:beta Carotene
D000318:Adrenergic beta-Agonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D007641:Keratolytic Agents; D010793:Phthalazines; D011804:Quinolines; D019207:beta Carotene; C014792:reproterol; D002338:Carotenoids; C011923:6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline); D009921:Metaproterenol; D005050:Etretinate; C044964:6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline); D013806:Theophylline; D013482:Superoxide Dismutase; D015474:Isotretinoin; C020976:azelastine